Allecra Therapeutics
Series BAllecra Therapeutics raised €22M in a Series B round in Jun 2016. The company is based in Weil am Rhein, Germany. Investors in the round: Delos Capital, Edmond de Rothschild Venture Capital, EMBL Ventures and 1 other. Data as of Nov 2026.
Amount raised
€22M
€22,000,000
Native amount
22,000,000 EUR
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €22M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jun 2016
Round type
series b
Amount (EUR)
€22M